NDC 70835-1001 - Cubicin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70835-1001
- Package NDCs from labels
- 70835-1001-2
- Manufacturer
- Curia New Mexico, LLC
- Effective date
- 2024-10-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cubicin - Curia New Mexico, LLC | Curia New Mexico, LLC | 2024-10-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70835-1001-2 | Cubicin | 350 mg in 1 VIAL | INJECTION | 350 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70835-1001 | CUBICIN (DAPTOMYCIN) INJECTION [CURIA NEW MEXICO, LLC] | 4 | 1 package rows | 20241016_3ca56472-49e1-593d-e054-00144ff8d46c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daptomycin | DAPTOMYCIN | Fresenius Kabi USA, LLC | fa514937-e025-4ea7-b62a-385eb056ae70 | 2022-11-30 | Warnings, Adverse reactions | NWQ5N31VKK |
| daptomycin | DAPTOMYCIN | Slate Run Pharmaceuticals, LLC | 3890474a-4425-43b3-97d4-5370cc35c2f7 | 2022-10-01 | Warnings, Adverse reactions | NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Fresenius Kabi USA, LLC | a990141d-7b92-48a5-a41d-1254522e2aa1 | 2022-06-09 | Warnings, Adverse reactions | NWQ5N31VKK |
| daptomycin | DAPTOMYCIN | Sagent Pharmaceuticals | f4ad8613-f25e-4b82-9621-cc5ff9525d3e | 2022-05-17 | Warnings, Adverse reactions | NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Hikma Pharmaceuticals USA Inc. | 1a7c9f52-7b58-49e9-93d7-5a26a7d1ef09 | 2022-04-29 | Warnings, Adverse reactions | NWQ5N31VKK |
| DAPZURA RT | DAPTOMYCIN | Baxter Healthcare Corporation | cb1283e1-35b8-425c-b338-d9ac0c7161f8 | 2022-01-25 | Warnings, Adverse reactions | NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Dr. Reddy's Laboratories Inc., | d750e28d-1353-4671-66a3-ea4e49e81e7b | 2021-10-04 | Warnings, Adverse reactions | NWQ5N31VKK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.